CEO/CSO of Progenics Pharmaceuticals Inc. (PGNX, Financial) Paul J Maddon buys 5,000 shares of PGNX on 10/04/2010 at an average price of $4.99 a share.
Progenics Pharmaceuticals Inc. has a market cap of $166.67 million; its shares were traded at around $5.08 with and P/S ratio of 3.41. Progenics Pharmaceuticals Inc. had an annual average earning growth of 5.6% over the past 10 years.
PGNX is in the portfolios of Paul Tudor Jones of The Tudor Group, Jim Simons of Renaissance Technologies LLC.
Progenics Pharmaceuticals Inc. has a market cap of $166.67 million; its shares were traded at around $5.08 with and P/S ratio of 3.41. Progenics Pharmaceuticals Inc. had an annual average earning growth of 5.6% over the past 10 years.
PGNX is in the portfolios of Paul Tudor Jones of The Tudor Group, Jim Simons of Renaissance Technologies LLC.
CEO Recent Trades:
- Buy: CEO/CSO Paul J Maddon bought 5,000 shares of PGNX stock on 09/01/2010 at the average price of 4.1. Paul J Maddon owns at least 839,057 shares after this. The price of the stock has increased by 23.9% since.
- Buy: CEO/CSO Paul J Maddon bought 5,000 shares of PGNX stock on 08/02/2010 at the average price of 4.75. Paul J Maddon owns at least 834,057 shares after this. The price of the stock has increased by 6.95% since.
- Buy: CEO/CSO Paul J Maddon bought 5,000 shares of PGNX stock on 07/16/2010 at the average price of 4.99. Paul J Maddon owns at least 829,057 shares after this. The price of the stock has increased by 1.8% since.
- Buy: CEO/CSO Paul J Maddon bought 5,000 shares of PGNX stock on 06/01/2010 at the average price of 4.99. Paul J Maddon owns at least 824,057 shares after this. The price of the stock has increased by 1.8% since.
- Buy: CEO/CSO Paul J Maddon bought 5,000 shares of PGNX stock on 05/20/2010 at the average price of 4.93. Paul J Maddon owns at least 819,057 shares after this. The price of the stock has increased by 3.04% since.
CFO Recent Trades:
- Sell: CFO Robert A Mckinney sold 4,000 shares of PGNX stock on 06/18/2010 at the average price of 6.25. Robert A Mckinney owns at least 32,925 shares after this. The price of the stock has decreased by 18.72% since.
Directors and Officers Recent Trades:
- Sell: VP, Research & Development William C Olson sold 2,364 shares of PGNX stock on 06/22/2010 at the average price of 5.81. William C Olson owns at least 35,494 shares after this. The price of the stock has decreased by 12.56% since.
- Sell: Sr. VP, Medical Affairs Robert J Israel sold 6,180 shares of PGNX stock on 06/22/2010 at the average price of 5.82. Robert J Israel owns at least 31,186 shares after this. The price of the stock has decreased by 12.71% since.
- Sell: Sr. VP, Product Dev. Thomas A Boyd sold 2,409 shares of PGNX stock on 06/22/2010 at the average price of 5.74. Thomas A Boyd owns at least 36,625 shares after this. The price of the stock has decreased by 11.5% since.
- Sell: President Mark Robert Baker sold 2,328 shares of PGNX stock on 06/22/2010 at the average price of 5.66. Mark Robert Baker owns at least 26,689 shares after this. The price of the stock has decreased by 10.25% since.
